GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RVL Pharmaceuticals RVLPQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 26 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on RVL Pharmaceuticals

Our reporting

We have not reported on RVL Pharmaceuticals yet.

Next results

13 Nov 2026

Due on 13 Nov 2026. Analysts expect earnings of -0.23 a share on revenue of $30.6m.

Past results

Reported against what analysts expected

29 Jun 202330 Mar 202328 Sept 202228 Jun 202229 Mar 202229 Dec 2021
Earnings per share-0.24-0.12-0.16-0.14-0.08-0.24
Forecast-0.11-0.12-0.16—-0.24—
Revenue$8.3m$8.8m$10.0m$8.4m$21.4m$2.9m
Forecast$10.6m$9.4m$10.0m—$8.4m—

Key events

  1. 12 Oct 2018Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.